$再生元制药(REGN)$ $赛诺菲-安万特(SNY)$

IL4R。小适应症失利，之前用过了IgE奥马珠单抗。

难治性，慢性自发性荨麻疹。

 Dupixent did not reach statistical significance in interim analysis despite numeric improvements observed across key endpoints.